Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

‍

Nature examines promising new cancer drugs targeting the protein KRAS, including Amgen's oral treatment Lumakras (sotorasib).

According to a new study, the market for Artificial Intelligence in clinical trials may grow to $4.8 billion over the next five years. (Managed Healthcare Executive)

Yesterday, Biogen presented an earnings report to investors and analysts. Most questions concerned its new Alzheimer’s drug, lecanemab. (BioPharma Dive)

The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!

‍

‍

Our Culture

"Because we work with the world’s top biopharma companies, we’ve created an adjudication template to speed the process. Judi provides our clients the necessary agility to develop innovative therapies."

 –Tyler, Trial Delivery
‍
‍

‍‍

‍

‍

About Judi

Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.